Showing results (661-670 of 1,375) with videos related to

Sort By:
Pageof 138
Drug Development Research|June 22, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer ActivityHaytham O Tawfik, Mohammed A Dahab, Mohamed R Elnagar, et al.
Drug Development Research|June 22, 2026
Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's DiseaseVinod Ugale, Nissi Sharon, Chandradip Salunkhe, et al.
Drug Development Research|May 29, 2025
Reactive Oxygen Species (ROS) and Their Profound Influence on Regulating Diverse Aspects of Cancer: A Concise ReviewRachana Tiwari, Ysani Mondal, Khyathi Bharadwaj, et al.
Drug Development Research|July 8, 2026
Design, Synthesis, and Evaluation of the Novel Benzimidazole Derivatives Inspired YC-1 as HIF-1α Inhibitor That Possess Anti-Colon Cancer PotentialQixian Yang, Jing Zhang, Meijing Liu, et al.
Drug Development Research|August 3, 2026
Applications of Bioinorganic Nano-Based Delivery Systems-Diagnostics and TherapeuticsFrank Ssengooba, Jubilee Andrew, Donald Fernandes
Drug Development Research|July 30, 2026
TrxR Inhibition and Nrf2-FOXO3 Modulation by Repurposed Drugs: A Redox Strategy to Reverse Cancer Multidrug ResistanceCharan Singh Pawar, Nagarajan Rajendra Prasad
Drug Development Research|August 10, 2026
Design, Synthesis, X-Ray Crystallographic Characterization, Anticholinesterase and Antioxidant Evaluation, and Molecular Modeling of Novel Dispiroindene-Pyrrolidine Derivatives as Multifunctional Anti-Alzheimer AgentsAisha A Alsfouk, Riham A El-Shiekh, Benson M Kariuki, et al.
Drug Development Research|August 17, 2026
Development of Phenoxyacetic Acid Hybrids With COX-2 Inhibitory Activity as Potential Anti-Neuroinflammatory AgentsMohammad H Alqarni, Mahmoud Abdelrahman Alkabbani, Aya Mohamed Ahmed Ibrahim, et al.
Drug Development Research|August 17, 2026
DSCAM-AS1 Facilitates Osteosarcoma Progression via Regulating miR-211-5p/PDCD6 AxisQi Wang, Yunzheng Zhao, Longyan Shi, et al.
Drug Development Research|August 20, 2026
Design, Synthesis, and Biological Evaluation of Benzimidazol-2-One Hybrids as Potential Anti-Alzheimer's Disease AgentsFatih Yılmaz, Emre Menteşe, Ozan Emre Eyüpoğlu, et al.
Pageof 138